TY - JOUR
T1 - Obesity is associated with increased risk of Crohn’s disease, but not ulcerative colitis: A pooled analysis of five prospective cohort studies
AU - Chan, Simon S. M.
AU - Chen, Ye
AU - Casey, Kevin
AU - Olen, Ola
AU - Ludvigsson, Jonas F.
AU - Carbonnel, Franck
AU - Oldenburg, Bas
AU - Gunter, Marc J.
AU - Tjønneland, Anne
AU - Grip, Olof
AU - DEFINe-IBD Investigators
AU - Lochhead, Paul
AU - Chan, Andrew T.
AU - Wolk, Alicia
AU - Khalili, Hamed
PY - 2022/5/1
Y1 - 2022/5/1
N2 - Background and Aims: It is unclear whether obesity is associated with the development of inflammatory bowel disease despite compelling data from basic science studies. We therefore examined the association between obesity and risk of Crohn's disease (CD) and ulcerative colitis (UC). Methods: We conducted pooled analyses of 5 prospective cohorts with validated anthropometric measurements for body mass index (BMI) and waist-hip ratio and other lifestyle factors. Diagnoses of CD and UC were confirmed through medical records or ascertained using validated definitions. We used Cox proportional hazards modeling to calculate pooled multivariable-adjusted HRs (aHRs) and 95% confidence intervals (CIs). Results: Among 601,009 participants (age range, 18-98 years) with 10,110,018 person-years of follow-up, we confirmed 563 incident cases of CD and 1047 incident cases of UC. Obesity (baseline BMI ≥30 kg/m
2) was associated with an increased risk of CD (pooled aHR, 1.34; 95% CI, 1.05-1.71, I
2 = 0%) compared with normal BMI (18.5 to <25 kg/m
2). Each 5 kg/m
2 increment in baseline BMI was associated with a 16% increase in risk of CD (pooled aHR, 1.16; 95% CI, 1.05-1.22; I
2 = 0%). Similarly, with each 5 kg/m
2 increment in early adulthood BMI (age, 18-20 years), there was a 22% increase in risk of CD (pooled aHR, 1.22; 95% CI, 1.05-1.40; I
2 = 13.6%). An increase in waist-hip ratio was associated with an increased risk of CD that did not reach statistical significance (pooled aHR across quartiles, 1.08; 95% CI, 0.97-1.19; I
2 = 0%). No associations were observed between measures of obesity and risk of UC. Conclusions: In an adult population, obesity as measured by BMI was associated with an increased risk of older-onset CD but not UC.
AB - Background and Aims: It is unclear whether obesity is associated with the development of inflammatory bowel disease despite compelling data from basic science studies. We therefore examined the association between obesity and risk of Crohn's disease (CD) and ulcerative colitis (UC). Methods: We conducted pooled analyses of 5 prospective cohorts with validated anthropometric measurements for body mass index (BMI) and waist-hip ratio and other lifestyle factors. Diagnoses of CD and UC were confirmed through medical records or ascertained using validated definitions. We used Cox proportional hazards modeling to calculate pooled multivariable-adjusted HRs (aHRs) and 95% confidence intervals (CIs). Results: Among 601,009 participants (age range, 18-98 years) with 10,110,018 person-years of follow-up, we confirmed 563 incident cases of CD and 1047 incident cases of UC. Obesity (baseline BMI ≥30 kg/m
2) was associated with an increased risk of CD (pooled aHR, 1.34; 95% CI, 1.05-1.71, I
2 = 0%) compared with normal BMI (18.5 to <25 kg/m
2). Each 5 kg/m
2 increment in baseline BMI was associated with a 16% increase in risk of CD (pooled aHR, 1.16; 95% CI, 1.05-1.22; I
2 = 0%). Similarly, with each 5 kg/m
2 increment in early adulthood BMI (age, 18-20 years), there was a 22% increase in risk of CD (pooled aHR, 1.22; 95% CI, 1.05-1.40; I
2 = 13.6%). An increase in waist-hip ratio was associated with an increased risk of CD that did not reach statistical significance (pooled aHR across quartiles, 1.08; 95% CI, 0.97-1.19; I
2 = 0%). No associations were observed between measures of obesity and risk of UC. Conclusions: In an adult population, obesity as measured by BMI was associated with an increased risk of older-onset CD but not UC.
KW - Body Mass Index
KW - Epidemiology
KW - Inflammatory Bowel Diseases
KW - Waist-Hip Ratio
UR - http://www.scopus.com/inward/record.url?scp=85113386738&partnerID=8YFLogxK
U2 - 10.1016/j.cgh.2021.06.049
DO - 10.1016/j.cgh.2021.06.049
M3 - Article
VL - 20
SP - 1048
EP - 1058
JO - Clinical Gastroenterology and Hepatology
JF - Clinical Gastroenterology and Hepatology
SN - 1542-3565
IS - 5
ER -